PTC Therapeutics
Logotype for PTC Therapeutics Inc

PTC Therapeutics (PTCT) investor relations material

PTC Therapeutics 44th Annual J.P. Morgan Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for PTC Therapeutics Inc
44th Annual J.P. Morgan Healthcare Conference summary12 Jan, 2026

Key business achievements and financial performance

  • Achieved $334 million annualized revenue run rate by Q3, with 100% year-over-year growth and GAAP profitability.

  • Maintained 70% gross margins despite subscale ASPs and underutilized lab capacity.

  • Delivered $153 million in GAAP revenue in 2024, exceeding projections, and guided 2025 revenue to $293–$299 million, with 2026 guidance raised to $415–$430 million.

  • Achieved profitability with only 10% of the accumulated deficits of public competitors.

  • Projected continued GAAP operating margin positivity for 2025 and 2026.

Technology and product innovation

  • Developed a patented single molecule next-generation sequencing platform enabling 10x better sensitivity and precision.

  • QCT technology allows for single molecule-level sensitivity, reducing noise and improving accuracy in cfDNA testing.

  • Unity prenatal test directly identifies fetal risk from maternal blood, detecting three times as many affected pregnancies as traditional methods.

  • Oncology products Northstar Select and Northstar Response offer 50%+ more actionable variant detection and earlier therapy response monitoring.

  • Technology enables both tumor-naive and tissue-free MRD testing, with plans to expand into early cancer detection.

Market strategy and growth drivers

  • Rapidly expanding test volume, with 51% year-over-year growth and increasing in-network coverage to over 250 million contracted lives.

  • Sales force is smaller than competitors but highly productive, adding 100 new clinics per quarter.

  • ASPs have surpassed $500 per test, with further growth expected from coding, contracting, and coverage improvements.

  • Oncology segment expected to grow faster than prenatal due to lower base and strong early indicators.

  • Guidance for 2026 does not depend on a specific sales rep headcount, but ongoing expansion is planned.

Sephience launch: bolus effect or sustained growth?
Votoplam accelerated approval pathway details
DMD franchise erosion: impact on 2026 guidance
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next PTC Therapeutics earnings date

Logotype for PTC Therapeutics Inc
Q4 20256 Mar, 2026
PTC Therapeutics
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next PTC Therapeutics earnings date

Logotype for PTC Therapeutics Inc
Q4 20256 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

PTC Therapeutics Inc is a biopharmaceutical company focused on discovering, developing, and commercializing treatments for rare disorders. The company uses proprietary platforms to develop small molecules and gene therapies. Its portfolio targets genetic disorders, oncology, and neurological conditions. The company is headquartered in South Plainfield, New Jersey, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage